9/3/2025E-nitiate Biopharma Secures ~¥200M in Series B Funding to Advance Au...

9/3/2025China to Become World's Third-Largest Innovative Drug Market by 2028:...

9/3/2025Ab&B Bio-Tech Gains Approval for First Quadrivalent Subunit Influenza ...

9/3/2025Aon Report Highlights Rapid Growth and Challenges in China's Health In...

9/3/2025China's Biopharma Industry Clusters: Mapping Opportunities and Regiona...

9/3/2025China Biopharma Tracker – August 2025 (PharmaDJ)

9/2/2025China's Clinical Trial Quality Management Faces Key Challenges Despite...

9/2/2025China Approved Seven New Drugs in August

9/2/2025Novatim and Radiance Forge Global Licensing Deal for Novel Cancer Ther...

9/2/2025Nine First-in-Class Drugs Receive Initial Clinical Approval in China

9/2/2025Astellas Accelerates Growth and Innovation in China

9/1/2025Hengrui Seeks NMPA Approval for New Dual-Receptor Obesity Drug HRS9531

9/1/2025Convalife's HKEX IPO Application Gets Green Light

9/1/2025Novel iPSC-Derived Neural Cell Therapy Shows Promise in SCI Treatment

9/1/2025Ennovabio Secures New Financing to Advance Pipeline for Immune and Met...

9/1/2025Hongcheng Launches Phase II Trial for PD-1/CTLA-4/VEGF TsAb in Advance...

9/1/2025Fosun Licenses Accro's TYK2/JAK1 Inhibitor AC-201 in Greater China

9/1/2025BioNTech Launches Phase 1/2 Trial of BNT327 and BNT3212 in Advanced Tu...

8/30/2025CMS Subsidiary Gets Approval to Launch Clinical Trials of Povorctinib

8/30/2025Recent Executive Moves

8/29/2025Akeso Advances First Bispecific ADC Into Clinical Stage With First Pat...

8/29/2025NHSA Announces Results of Form Review for 2025 NRDL Submissions

8/29/2025CDE Seeks Comment on ICH E6(R3) GCP Implementation Recommendations

8/29/2025CDE Solicits Comments on Draft Guideline for Post-Approval Change Mana...

8/29/2025CDE Invites Public Comment on 97th Batch of Reference Formulations for...

8/29/2025CDE Issues Technical Guideline for Non-Clinical Research of Vaccine Ad...

8/29/2025​​​​​​​CDE Issues Draft Requirements for Module 2 Chemistry Doc...

8/29/2025Hengrui's SHR2554 Receives Conditional NMPA Approval

8/29/2025Boehringer's Zongertinib Gains Conditional Approval in China

8/29/2025D3 Bio's D3S-001 Receives FDA Breakthru Therapy and Orphan Drug Design...

Page:3/789 Total number of articles:23668: [First][<<] [1] [2] [3] [4] [5] [>>] [End]